Eurestobart
Based on 1 Customer Validation
Eurestobart (ES002023) is a recombinant human IgG1 antibody against CD39. Eurestobart restores antitumor immunity by stabilizing the pro-inflammatory extracellular ATP (eATP) and interfering with synthesis of the immunosuppressive adenosine within the tumor microenvironment (TME). Eurestobart is used in the research of locally advanced and metastatic solid tumors.
For research use only. We do not sell to patients.
- Purity: 99%
- CAS No.: 2682847-53-4
- Molecular Weight:145.882 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 kappa
Human
ENTPD1/CD39
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 kappa
ELISA, FACS, Functional assay
-
Loaded Eurestobart on ProA biosensor, can bind HY-P75417 CD39 Protein, Human (sf9, His) with an affinity constant of 2.503E-09 M as determined in BLI assay.
Chemical Information
-
CAS No. 2682847-53-4
-
Appearance Liquid
-
Molecular Weight 145.882 kDa
-
Color Colorless to light yellow
-
SMILES
[Eurestobart]
-
Synonyms
ES002023; ES002
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)